Symptomatic Genetic Dilated Cardiomyopathy research hub

A Study of the Efficacy and Safety of Danicamtiv in Participants With Symptomatic Genetic and Familial Dilated Cardiomyopathy

This study is testing a new medication called danicamtiv for people with genetic or family-related dilated cardiomyopathy (DCM). It aims to see if danicamtiv is safe and helps the heart pump better, compared to a sugar pill.